Literature DB >> 25246097

Effectiveness of diffusion tensor imaging in assessing disease severity in Duchenne muscular dystrophy: preliminary study.

Skorn Ponrartana1, Leigh Ramos-Platt, Tishya Anne Leong Wren, Houchun Harry Hu, Thomas Gardner Perkins, Jonathan Mawlin Chia, Vicente Gilsanz.   

Abstract

BACKGROUND: There is currently a lack of suitable objective endpoints to measure disease progression in Duchenne muscular dystrophy (DMD). Emerging research suggests that diffusion tensor imaging (DTI) has potential as an outcome measure for the evaluation of skeletal muscle injury.
OBJECTIVE: The objective of this study was to evaluate the potential of DTI as quantitative magnetic resonance imaging (MRI) markers of disease severity in DMD.
MATERIALS AND METHODS: Thirteen consecutive boys (8.9 years ± 3.0 years) with DMD were evaluated using DTI. Fractional anisotropy (FA) and apparent diffusion coefficient (ADC) were compared with clinical outcome measures of manual muscle testing and MRI determinations of muscle fat fraction (MFF) in the right lower extremity.
RESULTS: Both MRI measures of FA and ADC strongly correlated with age and muscle strength. Values for FA positively correlated with age and negatively correlated with muscle strength (r = 0.78 and -0.96; both P ≤ 0.002) while measures of ADC negatively correlated age, but positively correlated with muscle strength (r = -0.87 and 0.83; both P ≤ 0.0004). Additionally, ADC and FA strongly correlated with MFF (r = -0.891 and 0.894, respectively; both P ≤ 0.0001). Mean MMF was negatively correlated with muscle strength (r = -0.89, P = 0.0001).
CONCLUSION: DTI measures of muscle structure strongly correlated with muscle strength and adiposity in boys with DMD in this pilot study, although these markers may be more reflective of fat replacement rather than muscle damage in later stages of the disease. Further studies in presymptomatic younger children are needed to assess the ability of DTI to detect early changes in DMD.

Entities:  

Mesh:

Year:  2014        PMID: 25246097     DOI: 10.1007/s00247-014-3187-6

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  38 in total

1.  Skipping to new gene therapies for muscular dystrophy.

Authors:  James G Tidball; Melissa J Spencer
Journal:  Nat Med       Date:  2003-08       Impact factor: 53.440

2.  T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments.

Authors:  Hee Kyung Kim; Tal Laor; Paul S Horn; Judy M Racadio; Brenda Wong; Bernard J Dardzinski
Journal:  Radiology       Date:  2010-06       Impact factor: 11.105

3.  Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.

Authors:  Hermien E Kan; Tom W J Scheenen; Marielle Wohlgemuth; Dennis W J Klomp; Ivonne van Loosbroek-Wagenmans; George W Padberg; Arend Heerschap
Journal:  Neuromuscul Disord       Date:  2009-03-28       Impact factor: 4.296

Review 4.  Fat and water magnetic resonance imaging.

Authors:  Thorsten A Bley; Oliver Wieben; Christopher J François; Jean H Brittain; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2010-01       Impact factor: 4.813

5.  Repeatability of chemical-shift-encoded water-fat MRI and diffusion-tensor imaging in lower extremity muscles in children.

Authors:  Skorn Ponrartana; Kristine E Andrade; Tishya A L Wren; Leigh Ramos-Platt; Houchun H Hu; Stefan Bluml; Vicente Gilsanz
Journal:  AJR Am J Roentgenol       Date:  2014-06       Impact factor: 3.959

6.  Water-fat separation with IDEAL gradient-echo imaging.

Authors:  Scott B Reeder; Charles A McKenzie; Angel R Pineda; Huanzhou Yu; Ann Shimakawa; Anja C Brau; Brian A Hargreaves; Garry E Gold; Jean H Brittain
Journal:  J Magn Reson Imaging       Date:  2007-03       Impact factor: 4.813

7.  Magnetic resonance imaging of mouse skeletal muscle to measure denervation atrophy.

Authors:  Jiangyang Zhang; Gang Zhang; Brett Morrison; Susumu Mori; Kazim A Sheikh
Journal:  Exp Neurol       Date:  2008-05-10       Impact factor: 5.330

8.  Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history.

Authors:  M H Brooke; G M Fenichel; R C Griggs; J R Mendell; R Moxley; J P Miller; M A Province
Journal:  Muscle Nerve       Date:  1983-02       Impact factor: 3.217

9.  Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy.

Authors:  Arne Fischmann; Patricia Hafner; Monika Gloor; Maurice Schmid; Andrea Klein; Urs Pohlman; Tanja Waltz; Rocio Gonzalez; Tanja Haas; Oliver Bieri; Dirk Fischer
Journal:  J Neurol       Date:  2012-11-09       Impact factor: 4.849

10.  Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months.

Authors:  Kieren G Hollingsworth; Penny Garrood; Michelle Eagle; Kate Bushby; Volker Straub
Journal:  Muscle Nerve       Date:  2013-08-30       Impact factor: 3.217

View more
  21 in total

1.  Muscle diffusion tensor imaging in glycogen storage disease V (McArdle disease).

Authors:  R Rehmann; L Schlaffke; M Froeling; R A Kley; E Kühnle; M De Marées; J Forsting; M Rohm; M Tegenthoff; T Schmidt-Wilcke; M Vorgerd
Journal:  Eur Radiol       Date:  2018-12-17       Impact factor: 5.315

Review 2.  Magnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.

Authors:  Doris G Leung
Journal:  J Neurol       Date:  2016-11-25       Impact factor: 4.849

3.  Fractional anisotropy and diffusivity changes in thyroid-associated orbitopathy.

Authors:  Ji Sung Han; Hyung Suk Seo; Young Hen Lee; Hwa Lee; Sang-Il Suh; Eun-Kee Jeong; Nabraj Sapkota; Ki Joon Kim
Journal:  Neuroradiology       Date:  2016-11-14       Impact factor: 2.804

4.  Optical polarization tractography revealed significant fiber disarray in skeletal muscles of a mouse model for Duchenne muscular dystrophy.

Authors:  Y Wang; K Zhang; N B Wasala; D Duan; G Yao
Journal:  Biomed Opt Express       Date:  2015-01-07       Impact factor: 3.732

5.  Loss of electrical anisotropy is an unrecognized feature of dystrophic muscle that may serve as a convenient index of disease status.

Authors:  Seward B Rutkove; Jim S Wu; Craig Zaidman; Kush Kapur; Sung Yim; Amy Pasternak; Lavanya Madabusi; Heather Szelag; Tim Harrington; Jia Li; Adam Pacheck; Basil T Darras
Journal:  Clin Neurophysiol       Date:  2016-10-13       Impact factor: 3.708

Review 6.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

7.  Quantitative Muscle MRI Protocol as Possible Biomarker in Becker Muscular Dystrophy.

Authors:  Lorenzo Maggi; Marco Moscatelli; Rita Frangiamore; Federica Mazzi; Mattia Verri; Alberto De Luca; Maria Barbara Pasanisi; Giovanni Baranello; Irene Tramacere; Luisa Chiapparini; Maria Grazia Bruzzone; Renato Mantegazza; Domenico Aquino
Journal:  Clin Neuroradiol       Date:  2020-01-23       Impact factor: 3.649

8.  Recurrence of carpal tunnel syndrome in isolated non-syndromic macrodactyly: DTI examination of a giant median nerve.

Authors:  Ignazio G Vetrano; Luca Maria Sconfienza; Domenico Albano; Vito Chianca; Vittoria Nazzi
Journal:  Skeletal Radiol       Date:  2018-10-20       Impact factor: 2.199

9.  Evaluation of skeletal muscle DTI in patients with duchenne muscular dystrophy.

Authors:  M T Hooijmans; B M Damon; M Froeling; M J Versluis; J Burakiewicz; J J G M Verschuuren; E H Niks; A G Webb; H E Kan
Journal:  NMR Biomed       Date:  2015-10-09       Impact factor: 4.044

10.  Signal-to-noise ratio assessment of muscle diffusion tensor imaging using single image set and validation by the difference image method.

Authors:  Zhiyue J Wang; Jin Yamamura; Sarah Keller
Journal:  Br J Radiol       Date:  2019-07-26       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.